Co-GP / Platform:A family office could deploy into the Chicago life sciences market by backing a sponsor/operator at the GP level, focusing on established developments like Fulton Labs.

Co-GP / Platform:A family office could deploy into this market by partnering with established operators in Tysons Corner to share in the promote and access a pipeline of high-quality assets.

Co-GP / Platform:A family office could deploy into the Washington, D.C. life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of emerging opportunities.

Co-GP / Platform:A family office could deploy into this market by partnering with established operators on build-to-suit projects, sharing in the promote and benefiting from a strong construction pipeline.

Co-GP / Platform:A family office could deploy into the Denver office market by backing a sponsor focused on acquiring or developing Class A properties in high-demand submarkets.

Co-GP / Platform:A family office could deploy into the Toronto office market by partnering with a sponsor focused on revitalizing Class B and Class C assets in non-CBD submarkets.

Co-GP / Platform:A family office could deploy into this market by partnering with established operators to co-GP on trophy office assets, sharing in the promote and benefiting from a repeatable pipeline.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor focused on innovative cost-saving measures at the GP level.

Co-GP / Platform:A family office could deploy into the Chicago life sciences market by backing a sponsor/operator at the GP level, particularly in light of the high vacancy rates that may necessitate innovative leasing strategies.

Co-GP / Platform:A family office could deploy into this market by partnering with established life sciences operators in emerging markets to share in the promote and enhance their investment returns.

Co-GP / Platform:A family office could deploy into the Chicago industrial market by backing a sponsor/operator at the GP level, focusing on projects that can adapt to the current demand challenges.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor/operator at the GP level, sharing in the promote and benefiting from the strong pipeline of life sciences developments.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor/operator at the GP level, focusing on life sciences projects that have been deferred or abandoned.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and benefiting from the strong capital inflow.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and gaining access to a pipeline of projects.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and benefiting from a strong deal flow.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor like IQHQ or Boston Global Investors LLC at the GP level to share in the promote from their life sciences developments.

Co-GP / Platform:A family office could deploy into the Seattle life sciences market by backing a sponsor/operator focused on innovative medical technologies to share in the promote.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor/operator at the GP level, particularly in funding developments like the HELIX life sciences campus.

Co-GP / Platform:A family office could deploy into the Philadelphia life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and benefiting from a strong pipeline of developments.

Co-GP / Platform:A family office could deploy into Atlanta's industrial market by backing a sponsor/operator at the GP level, focusing on those with a proven track record in managing logistics properties.

Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a sponsor/operator at the GP level, particularly in the development of new facilities like those at Pacific Center.

Co-GP / Platform:A family office could deploy into the San Francisco Bay Area life sciences market by backing a sponsor/operator at the GP level, capitalizing on the current high vacancy rates to negotiate favorable terms.

Co-GP / Platform:A family office could deploy into the New York life sciences market by backing a sponsor/operator involved in the development of new biotech facilities or leasing projects.